In 1941, Saul Hertz successfully treated the first metastatic thyroid cancer patient with131iodine.1In the last few years, the field of theranostics has expanded significantly with the advent of177Lu-DOTATATE and177Lu-prostate-specific membrane antigen (PSMA) therapies. Here, FOLH1 is linked to thyroid gland carcinoma.